Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates

Journal of Molecular Biology

Volumn 421, Issue 4-5, 2012, Pages 616-630

  Saridaki, Theodora ^a   Zampagni, Mariagioia ^a   Mannini, Benedetta ^a   Evangelisti, Elisa ^a   Taddei, Niccolò ^a   Cecchi, Cristina ^a   Chiti, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

glycosaminoglycans; HypF N aggregate toxicity; MTT reduction assay; PM labeling; protein deposition diseases

Indexed keywords

AMYLOID BETA PROTEIN; ESCHERICHIA COLI PROTEIN; GLYCOSAMINOGLYCAN; HEPARIN; OLIGOMER; PROTEIN HYPF N; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURFACE; CHO CELL; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN;

CRICETULUS GRISEUS; ESCHERICHIA COLI;

EID: 84864284188     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.02.007     Document Type: Article

References (60)

1. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75 2006 333 366 (Pubitemid 44118036)
2. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution J. Mol. Med. 81 2003 678 699 (Pubitemid 37491594)
3. Finder V.H., and Glockshuber R. Amyloid-β aggregation Neurodegener. Dis. 4 2007 13 27
4. Walsh D.M., and Selkoe D.J. Aβ oligomers - a decade of discovery J. Neurochem. 101 2007 1172 1184
5. Bellotti V., and Chiti F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases Curr. Opin. Struct. Biol. 18 2008 771 779
6. Bush A.I. The metallobiology of Alzheimer's disease Trends Neurosci. 26 2003 207 214 (Pubitemid 36412003)
7. 2- microglobulin amyloid fibrils in the presence of type I collagen J. Biol. Chem. 283 2008 4912 4920
8. Pepys M.B., Rademacher T.W., Amatayakul-Chantler S., Williams P., Noble G.E., and Hutchinson W.L. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure Proc. Natl Acad. Sci. USA 91 1994 5602 5606 (Pubitemid 24174376)
9. Bales, K. R., Dodart, J. C., DeMattos, R. B., Holtzman, D. M. & Paul, S. M. (2002). Apolipoprotein E, amyloid, and Alzheimer disease. Mol. Interv. 2, 363-375, 339.
10. Ancsin J.B. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit Amyloid 10 2003 67 79 (Pubitemid 36936537)
11. Capila I., and Linhardt R.J. Heparin-protein interactions Angew. Chem., Int. Ed. Engl. 41 2002 391 412
12. Rabenstein D.L. Heparin and heparan sulfate: structure and function Nat. Prod. Rep. 19 2002 312 331 (Pubitemid 34656777)
13. Bosman F.T., and Stamenkovic I. Functional structure and composition of the extracellular matrix J. Pathol. 200 2003 423 428 (Pubitemid 36818243)
14. Alexandrescu A.T. Amyloid accomplices and enforcers Protein Sci. 14 2005 1 12 (Pubitemid 40054111)
15. 3, common in heparin, has a strict topography and is involved in cell behavior and disease J. Biol. Chem. 285 2010 41143 41151
16. Cohlberg J.A., Li J., Uversky V.N., and Fink A.L. Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro Biochemistry 41 2002 1502 1511 (Pubitemid 34112739)
17. Castillo G.M., Lukito W., Wight T.N., and Snow A.D. The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation J. Neurochem. 72 1999 1681 1687 (Pubitemid 29140844)
18. McLaurin J., Franklin T., Zhang X., Deng J., and Fraser P.E. Interactions of Alzheimer amyloid-β peptides with glycosaminoglycans effects on fibril nucleation and growth Eur. J. Biochem. 266 1999 1101 1110 (Pubitemid 30010129)
19. 2-microglobulin amyloid fibrils in vitro Kidney Int. 64 2003 1080 1088 (Pubitemid 37013846)
20. Suk J.Y., Zhang F., Balch W.E., Linhardt R.J., and Kelly J.W. Heparin accelerates gelsolin amyloidogenesis Biochemistry 45 2006 2234 2242 (Pubitemid 43271322)
21. Meng F., Abedini A., Song B., and Raleigh D.P. Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes Biochemistry 46 2007 12091 12099 (Pubitemid 350022365)
22. McLaughlin R.W., De Stigter J.K., Sikkink L.A., Baden E.M., and Ramirez-Alvarado M. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein Protein Sci. 15 2006 1710 1722
23. Calamai M., Kumita J.R., Mifsud J., Parrini C., Ramazzotti M., and Ramponi G. Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes Biochemistry 45 2006 12806 12815 (Pubitemid 44630867)
24. Motamedi-Shad N., Monsellier E., Torrassa S., Relini A., and Chiti F. Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway J. Biol. Chem. 284 2009 29921 29934
25. Woods A.G., Cribbs D.H., Whittemore E.R., and Cotman C.W. Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons Brain Res. 697 1995 53 62
26. Pollack S.J., Sadler I.I., Hawtin S.R., Tailor V.J., and Shearman M.S. Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion Neurosci. Lett. 197 1995 211 214
27. Pollack S.J., Sadler I.I., Hawtin S.R., Tailor V.J., and Shearman M.S. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells Neurosci. Lett. 184 1995 113 116
28. Sadler I.I., Smith D.W., Shearman M.S., Ragan C.I., Tailor V.J., and Pollack S.J. Sulphated compounds attenuate beta-amyloid toxicity by inhibiting its association with cells NeuroReport 7 1995 49 53 (Pubitemid 26078171)
29. Bergamaschini L., Donarini C., Rossi E., De Luigi A., Vergani C., and De Simoni M.G. Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro Neurobiol. Aging 23 2002 531 536 (Pubitemid 34495463)
30. Sandwall E., O'Callaghan P., Zhang X., Lindahl U., Lannfelt L., and Li J.P. Heparan sulfate mediates amyloid-beta internalization and cytotoxicity Glycobiology 20 2010 533 541
31. Rosano C., Zuccotti S., Bucciantini M., Stefani M., Ramponi G., and Bolognesi M. Crystal structure and anion binding in the prokaryotic hydrogenase maturation factor HypF acylphosphatase-like domain J. Mol. Biol. 321 2002 785 796
32. Chiti F., Bucciantini M., Capanni C., Taddei N., Dobson C.M., and Stefani M. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain Protein Sci. 10 2001 2541 2547 (Pubitemid 33091578)
33. Relini A., Torrassa S., Rolandi R., Gliozzi A., Rosano C., and Canale C. Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils J. Mol. Biol. 338 2004 943 957 (Pubitemid 38542824)
34. Marcon G., Plakoutsi G., Canale C., Relini A., Taddei N., and Dobson C.M. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state J. Mol. Biol. 347 2005 323 335 (Pubitemid 40312462)
35. Campioni S., Mossuto M.F., Torrassa S., Calloni G., de Laureto P.P., and Relini A. Conformational properties of the aggregation precursor state of HypF-N J. Mol. Biol. 379 2008 554 567
36. Campioni S., Mannini B., Zampagni M., Pensalfini A., Parrini C., and Evangelisti E. A causative link between the structure of aberrant protein oligomers and their toxicity Nat. Chem. Biol. 6 2010 140 147
37. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., and Zurdo J. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511 (Pubitemid 34288846)
38. Bucciantini M., Calloni G., Chiti F., Formigli L., Nosi D., Dobson C.M., and Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity J. Biol. Chem. 279 2004 31374 31382 (Pubitemid 39037804)
39. Cecchi C., Baglioni S., Fiorillo C., Pensalfini A., Liguri G., and Nosi D. Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates J. Cell Sci. 118 2005 3459 3470 (Pubitemid 41246100)
40. Baglioni S., Casamenti F., Bucciantini M., Luheshi L.M., Taddei N., and Chiti F. Prefibrillar amyloid aggregates could be generic toxins in higher organisms J. Neurosci. 26 2006 8160 8167 (Pubitemid 44315140)
41. Zampagni M., Cascella R., Casamenti F., Grossi C., Evangelisti E., and Wright D. A comparison of the biochemical modifications caused by toxic and nontoxic protein oligomers in cells J. Cell Mol. Med. 15 2010 2106 2116
42. Canale C., Torrassa S., Rispoli P., Relini A., Rolandi R., and Bucciantini M. Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers Biophys. J. 91 2006 4575 4588 (Pubitemid 44904242)
43. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
44. 581/591 FEBS Lett. 453 1999 278 282 (Pubitemid 29326663)
45. 581/591 Free Radical Biol. Med. 36 2004 1635 1644 (Pubitemid 38746569)
46. Cecchi C., Pensalfini A., Stefani M., Baglioni S., Fiorillo C., and Cappadona S. Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity J. Mol. Med. 86 2008 197 209 (Pubitemid 351172125)
47. Cecchi C., Rosati F., Pensalfini A., Formigli L., Nosi D., and Liguri G. Seladin-1/DHCR24 protects neuroblastoma cells against Aβ toxicity by increasing membrane cholesterol content J. Cell Mol. Med. 12 2008 1990 2002
48. Clement M.V., Ponton A., and Pervaiz S. Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu FEBS Lett. 440 1998 13 18 (Pubitemid 28558725)
49. Hammarstrφm P., Kalman B., Jonsson B.H., and Carlsson U. Pyrene excimer fluorescence as a proximity probe for investigation of residual structure in the unfolded state of human carbonic anhydrase II FEBS Lett. 420 1997 63 68 (Pubitemid 28037201)
50. Krishnan R., and Lindquist S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity Nature 435 2005 765 772 (Pubitemid 40839721)
51. Ryser H.J., Morad N., and Shen W.C. Heparin interaction with cultured cells: possible role of fibronectin in uncoupling surface binding and endocytosis Cell Biol. Int. Rep. 7 1983 923 930 (Pubitemid 14205588)
52. Barzu T., Molho P., Tobelem G., Petitou M., and Caen J. Binding and endocytosis of heparin by human endothelial cells in culture Biochim. Biophys. Acta 845 1985 196 203 (Pubitemid 15067878)
53. Castellot J.J. Jr., Wong K., Herman B., Hoover R.L., Albertini D.F., and Wright T.C. Binding and internalization of heparin by vascular smooth muscle cells J. Cell. Physiol. 124 1985 13 20 (Pubitemid 15042633)
54. Esko J.D., Stewart T.E., and Taylor W.H. Animal cell mutants defective in glycosaminoglycan biosynthesis Proc. Natl Acad. Sci. USA 82 1985 3197 3201 (Pubitemid 15029573)
55. Esko J.D., Montgomery R.I., and Lindahl U. Secretory heparin in murine mastocytoma cell lines Biochem. Soc. Trans. 18 1990 807 809 (Pubitemid 20359310)
56. Lindahl U. Biosynthesis of heparin Biochem. Soc. Trans. 18 1990 803 805 (Pubitemid 20359308)
57. van Horssen J., Wesseling P., van den Heuvel L.P., de Waal R.M., and Verbeek M.M. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders Lancet Neurol. 2 2003 482 492 (Pubitemid 36876105)
58. Capila I., Hernaiz M.J., Mo Y.D., Mealy T.R., Campos B., and Dedman J.R. Annexin V-heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surfaces Structure 9 2001 57 64 (Pubitemid 32064350)
59. Dahlgren K.N., Manelli A.M., Stine W.B. Jr., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053 (Pubitemid 34969015)
60. Pensalfini A., Zampagni M., Liguri G., Becatti M., Evangelisti E., and Fiorillo C. Membrane cholesterol enrichment prevents Aβ-induced oxidative stress in Alzheimer's fibroblasts Neurobiol. Aging 32 2011 210 222